期刊文献+

DNA修复酶基因MGMT启动子区异常甲基化与食管癌的关系 被引量:5

Correlation of Promoter Hyper-methylation of O^6-methylguanine-DNA Methyltransferase Gene and the Risk for Esophageal Cancer
下载PDF
导出
摘要 背景与目的:分析食管癌组织中MGMT启动子区CpG岛甲基化状态和食管癌发病风险的关系,探讨MGMT基因启动子的异常甲基化在食管癌筛查及早期诊断中的意义。材料与方法:对江苏淮安的91例新发食管癌病例的癌组织、癌旁组织及外周血血浆样本提取DNA,应用甲基化特异性PCR(MSP)分析MGMT启动子区CpG岛的甲基化状态;对食管癌组织和癌旁组织提取总RNA,采用SYBRGREENI实时荧光定量逆转录-聚合酶链反应(RT-PCR)测定MGMT的mRNA水平。结果:MGMT启动子区CpG岛异常甲基化与食管癌发病风险增高有关联(OR=7.750,95%CI=2.736~21.955);MGMT启动子区CpG岛甲基化状态与MGMTmRNA水平无显著相关;血浆循环DNA中MGMT启动子区CpG岛甲基化与癌组织中MGMT启动子区CpG岛甲基化相关(P<0.01),血浆循环DNA中MGMT启动子区CpG岛甲基化检出率与癌组织中MGMT启动子区CpG岛甲基化检出率中度相关(Kappa=0.603,P<0.01)。结论:MGMT基因的启动子区CpG岛的异常甲基化与食管癌发病风险增加有关;检测血浆循环DNA中MGMT基因启动子的异常甲基化,可为食管癌的筛查、早期诊断提供有价值的信息。 BACKGROUND AND AIM:To analyze whether promoter methylation of O6-methylguanine-DNA methyltransferase(MGMT)gene is associated with the risk for esophageal squamous cell carcinoma(ESCC),and to evaluate the clinical significance in the screening and early diagnosis of ESCC.MATERIALS AND METHODS:91 patients with newly diagnosed,untreated esophageal cancer were recruited in the present study.Esophageal cancer tissues,tissues adjacent to the tumors and peripheral blood were collected to determine CpG island hypermethylation of the promoter.Methylation specific PCR(MSP)was used to examine the methylation status of MGMT gene,total mRNA was extracted from esophageal cancer tissues and tissues adjacent to the tumors,expression levels of MGMT gene were measured by quantitative real-time reverse transcription-PCR.RESULTS:The risk for ESCC showed significant correlation to promoter hypermethylation of MGMT gene(OR=7.750,95%CI=2.736~21.955).There was no significant correlation between methylation status and mRNA level.Hypermethylation of MGMT gene in plasma from ESCC patients was significantly correlated to that in tumor tissue(P〈0.01).The detection rate of CpG island hypermethylation of MGMT promoter in plasma was moderately correlated with that in tumor tissue(Kappa=0.603,P〈0.01).CONCLUSION:This study suggested that CpG island hyper-methylation of MGMT gene was associated with an enhanced risk for ESCC.Detection of the aberrant methylation in the promoter of MGMT gene from ESCC patient plasma might provide valuable information for the screening and early diagnosis of ESCC.
出处 《癌变.畸变.突变》 CAS CSCD 2009年第2期105-108,共4页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 国家自然科学基金资助项目(30571540 30671732 30800891) 江苏省预防医学基金项目(Y2006007)
关键词 食管癌 MGMT 甲基化 循环DNA esophageal cancer O6-methylguanine-DNA methyltransferase methylation circulating DNA
  • 相关文献

参考文献14

  • 1Sanchez-Cespedes M,Esteller M, Wu L, et al. Gene promoter hypennethylation in tumors and serum of head and neck cancer patients [ J ]. Cancer Res, 2000, 60(4) : 892 - 895. 被引量:1
  • 2Fang MZ, Wang Y, Ai N, et al. Tea Polyphenol(-) -epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines [J]. Cancer Res, 2003, 63(22) : 7563 - 7570. 被引量:1
  • 3Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^-ΔΔCT method [J]. Methods, 2001,25(4) :402 - 408. 被引量:1
  • 4Tanaka S,Kobayashi I, Utsuki S, et al. O^6-methylguanine-DNA methyhranspherasc gene expression in gliomas by means of real-time quantitative RT-PCR and clinical response to nitrosoureas [ J ]. Int J Cancer, 2003, 103 ( 1 ) : 67 - 72. 被引量:1
  • 5Ishikawa T, Zhang SS, Qin X, et al. DNA repair an cancer: lessons from mutantmousemodels[J] .Cancer Sci, 2004, 95(2): 112- 117. 被引量:1
  • 6Baylin SB, Herrnam JG. DNA hypermethylation in tumorigenesis : epigeneties joins genetics [J] . Trends Genet, 2000, 16(4): 168-174. 被引量:1
  • 7Liu Y, Lan Q, Siegfried JM, et al. Aberrant promoter methylation of P16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer Patients[J] Neoplasia, 2006, 8(1) :46- 51. 被引量:1
  • 8Roth MJ, Abnet CC, Hu N, et al. p16, MGMT, RARbeta2, CLD3, CRBP and MTIG gene methylation in esophageal squamous cell carcinoma and its precursor lesions[J] . Oncol Rep, 2006, 15(6) : 1591 - 1597. 被引量:1
  • 9Shen L, Kondo Y, Rosner GL, et al. MGMT promoter methylamine and field defect in sporadic eolorectal cancer [J]. J Nall Cancer Ins1,2005,97(18) : 1330- 1338. 被引量:1
  • 10Fujiwara K, Fujimoto N, Tabata M, et al. Identification of epigenetie aberrant promoter methylation in serum DNA is useful for early detection of lung cancer[J]. Clin Cancer Res, 2005, 11(3) : 1219- 1225. 被引量:1

二级参考文献41

  • 1吴健民.对肿瘤标志物的再认识[J].中华检验医学杂志,2005,28(1):11-13. 被引量:116
  • 2Ziegler A, Zangemeister-Wittke U, Stahel RA. Circulating DNA :a new diagnostic gold mine? [ J ]. Cancer Treat Rev, 2002,28(5) :255 -271. 被引量:1
  • 3Silva JM, Garcia JM, Dominguez G, et al. Persistence of tumor DNA in plasma of breast cancer patients after mastectomy [ J ].Ann Surg Oncol, 2002,9( 1 ) :71 -76. 被引量:1
  • 4Silva JM ,Silva J ,Sanchez A,et al. Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of diseaseree survival[ J]. Clin Cancer Res, 2002,8 ( 12 ) :3761 - 3766. 被引量:1
  • 5Wang BG, Huang HY, Chen YC, et al, Increased plasma DNA integrity in cancer patients [ J ]. Cancer Res, 2003,63 : 3966 -3968. 被引量:1
  • 6Gastells A,Puig P, Mora J,et al. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance[J]. J Clin Oncol, 1999,17(2) :578 -584. 被引量:1
  • 7Kopreski MS, Benko FA, Borys D J, et al. Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA [ J ]. J Natl Cancer Inst, 2000,92(11) :918 -923. 被引量:1
  • 8Shao ZM, Wu J,Shen ZZ,et al. p53 mutation in plasma DNA and its prognostic value in bresat cancer patients [ J ]. Clin Cancer Res, 2001,7 ( 8 ) :2222 - 2227. 被引量:1
  • 9Kirk GD, Gamus-Randon AM, Mendy M. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from the Gambia[ J]. J Natl Cancer Inst, 2000,92(2) :148 - 153. 被引量:1
  • 10Usadel H, Brabender J, Danenberg KD. Quantitative adenomatous polyposis coil promoter methylatlon analysis in tumor tissue, serum,and plasma DNA of patients with lung cancer [ J]. Cancer Res, 2002,62 ( 2 ) :371 - 375. 被引量:1

共引文献41

同被引文献90

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部